Search Results for "ribavirin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for ribavirin. Results 1 to 4 of 4 total matches.
Drugs for Hepatitis C Virus Infection
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
) plus ribavirin is the treatment of choice in patients with
decompensated cirrhosis.
▶ Options ...
About 2.5 million persons in the US had hepatitis C
between 2017 and 2020. Guidelines from the American
Association for the Study of Liver Diseases (AASLD)
and the Infectious Diseases Society of America (IDSA)
on management of hepatitis C virus (HCV) infection
were updated in 2023.
Med Lett Drugs Ther. 2024 Oct 28;66(1714):169-74 doi:10.58347/tml.2024.1714a | Show Introduction Hide Introduction
Figure 1: Treatment of Hepatitis C Virus Infection in Treatment-Naive Adults (online only)
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
1a.
4.Addition of ribavirin is an alternative for patients with compensated cirrhosis ...
View Figure 1: Treatment of Hepatitis C Virus Infection in Treatment-Naive Adults
Med Lett Drugs Ther. 2024 Oct 28;66(1714):e174 doi:10.58347/tml.2024.1714e | Show Introduction Hide Introduction
Table 3: Some Drug Interactions with DAAs for HCV Infection (online only)
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
ledipasvir elbasvir grazoprevir glecaprevir DAA hepatitis C ribavirin Mavyret Harvoni Sovaldi Epclusa Vosevi ...
View Table 3: Some Drug Interactions with DAAs for HCV Infection
Med Lett Drugs Ther. 2024 Oct 28;66(1714):e175 doi:10.58347/tml.2024.1714f | Show Introduction Hide Introduction
Drugs for Multiple Sclerosis
The Medical Letter on Drugs and Therapeutics • Mar 22, 2021 (Issue 1620)
to become active (e.g., ribavirin)
could interfere with intracellular phosphorylation
of cladribine ...
Most patients with multiple sclerosis (MS) present
with the relapsing-remitting form of the disease.
Pharmacologic treatment usually includes a
disease-modifying drug, corticosteroids for acute
exacerbations, and other drugs for managing
symptoms such as fatigue, depression, and pain.
Early use of disease-modifying therapy has improved
clinical outcomes.